The Art Directors Guild ‘s 29th annual Excellence in Production Design Awards for film, TV and theater are being handed out ...

EE BAFTA Film Awards longlist is out, and it’s packed with potential winners. From animated family favorites to Oscar-bait dramas, the competition is fierce this year. While final nominations drop on ...

The best movie of 2023 is now the best movie on Prime Video. Director and screenwriter Christopher Nolan will have a hard ...

Money makes money - and these six South Africans have made a lot of it over the years. And by a lot, we mean a LOT!

Assimon, who joined De Beers in 2020 and served for three years as CEO of Forevermark, helped to sharpen the De Beers image ...

Fusion Family Wealth LLC boosted its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 10.0% during the fourth quarter, according to the company in its most recent filing with the ...

Oppenheimer cut shares of Cloudflare (NYSE:NET – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Friday morning, Marketbeat reports. Several ...

“I don’t think the family will ever be able to come back to what it was, especially after this,” said Mendez. But Jerry Oppenheimer, author of “The Other Mrs Kennedy: An Intimate and ...

Other confirmed cast members include Safdie's Oppenheimer co-star Matt Damon, as well as Tom Holland, Zendaya, Robert Pattinson, Lupita Nyong’o, Anne Hathaway, Charlize Theron, and Jon Bernthal.

Apple (AAPL, Financials) was downgraded to Perform from Outperform by Oppenheimer ahead of its first-quarter fiscal 2025 earnings report, with analysts citing slowing iPhone sales and competitive ...

R Madhavan expressed disappointment with Hollywood, criticizing Christopher Nolan's 'Oppenheimer' for lacking emotional depth. He feels the industry has "lost the plot," moving away from impactful ...

Exelixis (NASDAQ:EXEL) is down 5.95% to $32.10 as of 11:04 AM ET Friday, following a downgrade from Oppenheimer, which cut its rating to Perform from Outperform due to concerns over drug ...